CNP Q1 2026 Earnings Slight EPS Miss Amid Modest Stock Gains BLDR Q1 2026 Earnings EPS Misses Estimates by 284 Stock Edges Higher Processa Pharmaceuticals Inc PCSA Q4 2025 Earnings WiderThanExpected Loss as Clinical Pipeline Progresses ADNT Q1 2026 Earnings EPS Surpasses Estimates by 172 on Strong Operational Execution OppFi Inc Q1 2026 Earnings EPS Surpasses Estimates Amidst Solid Operational Performance Fulcrum Therapeutics Q1 2026 Earnings Narrowed Loss Exceeds Analyst Expectations